Project Details
| Short title | 17000139BLC2001 |
|---|---|
| Acronym | TAR-200 |
| Status | Active |
| Effective start/end date | 13/08/21 → 15/04/26 |
Phase 2b Clinical Study Evaluating Efficacy and Safety of TAR-200 in Combination with Cetrelimab, TAR-200 Alone, or Cetrelimab Alone in Participants with High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Intravesical Bacillus Calmette-Guerin (BCG) who are Ineligible for or Elected Not to Undergo Radical Cystectomy
- Patel, Manish (Primary Chief Investigator)
- Chapman, Nicola (Clinical Trial Unit Staff)
- Tan, Pearlyn (Clinical Trial Unit Staff)
Project: Research